Johnson & Johnson, US4781601046

Johnson & Johnson stock holds firm on strong Q2 results

Published on 09/12/2026 at 14:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock opened at USD 265.91 on September 12, 2026, with a market cap of USD 640.82 billion. MarketBeat said Q2 revenue was USD 25.31 billion and EPS was USD 2.90.

Modern hospital operating room with robotic surgical arms positioned above a draped patient, surgeons in blue sterile gowns monitoring vital-sign and anatomy screens, bright overhead surgical lighting, stainless steel instrument trays in the foreground
Johnson und US4781601046 zeigen modernen Krankenhaus OP mit Robotik Chirurgie und medizinischen Bildschirmen, Illustration mit AI erstellt.

Johnson & Johnson stock (ISIN US4781601046) opened at USD 265.91 on September 12, 2026, with a market capitalization of USD 640.82 billion and a 52-week range of USD 173.33 to USD 281.07. The shares sat close to the top of that band, while the latest cited quarter showed revenue of USD 25.31 billion and EPS of USD 2.90.

Q2 still sets the tone

According to MarketBeat, Johnson & Johnson reported Q2 earnings on July 15, 2026, with EPS of USD 2.90, ahead of the USD 2.84 consensus by USD 0.06. The same report put revenue at USD 25.31 billion, up 6.6 percent year over year.

That mix matters for valuation. MarketBeat also cited FY 2026 guidance of USD 11.60 to USD 11.75 in EPS, while analysts on the same platform expected USD 11.61 for the current fiscal year.

RBC sticks to Buy

According to The Globe and Mail, RBC Capital kept its Buy rating on September 12, 2026 and pointed to an average price target of USD 287.59 for Johnson & Johnson. The same report described that as a 7.68 percent upside from current levels.

For investors, the gap between USD 265.91 and USD 287.59 is the key market marker right now. The stock is trading about USD 21.68 below that target.

Price stays near highs

Johnson & Johnson stock closed the latest session at a level that still leaves it inside the upper part of its 52-week range, with the market cap at USD 640.82 billion on September 12, 2026. The combination of USD 265.91, USD 281.07 and USD 640.82 billion is the current reference set.

Johnson & Johnson stock facts

  • Company: Johnson & Johnson
  • ISIN: US4781601046
  • Ticker: JNJ
  • Trading venue: NYSE
  • Price (as of September 12, 2026): USD 265.91
  • Market capitalization: USD 640.82 billion (as of September 12, 2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: Dow Jones Industrial Average

More news and analyses on Johnson & Johnson stock

Disclaimer...

en | US4781601046 | JOHNSON & JOHNSON | boerse | 70093148 | bgmi